From "Food Noise" to "Drug Noise": How One Phrase Changed Addiction Medicine

The Origin of "Food Noise"

The term "food noise" didn't come from a lab. It came from patients. People taking semaglutide for weight loss began describing their experience in strikingly consistent language: the constant mental chatter about food — what to eat next, when to eat, craving for specific textures and flavors — simply went quiet. For people who had lived with intrusive food thoughts dominating their mental bandwidth for years or decades, the silence was often described as the most dramatic effect of the medication.

The phrase caught fire. It spread across patient forums, through media coverage, and eventually into clinical conversations. "Food noise" gave language to an experience that millions of people recognized but had never been able to articulate — the persistent, exhausting preoccupation with eating that goes far beyond physical hunger.

The Leap to "Drug Noise"

Dr. Ziyad Al-Aly, the WashU Medicine clinical epidemiologist who led the 606,434-veteran BMJ study, made the conceptual leap explicit. In his research and public communications, he began using the term "drug noise" to describe the analogous experience in addiction: the relentless, intrusive craving that drives people toward their substance of choice regardless of consequences.

"People taking these drugs for obesity often describe a quieting of 'food noise,' the persistent preoccupation with food that drives overeating," Al-Aly wrote. "What our study suggests is something broader: GLP-1 drugs may also quiet what I call 'drug noise,' the relentless craving that drives addiction across substances."

The metaphor is powerful because it draws a direct biological parallel. If the same medication quiets both food noise and drug noise, it implies both arise from the same neural machinery — the incentive salience system driven by dopamine signaling in reward circuits.

Why Language Matters

The food noise/drug noise framing does something important for addiction: it normalizes craving as a biological phenomenon rather than a moral failing. When someone says "I can't stop thinking about food," we understand that as a physiological drive. The parallel phrasing — "I can't stop thinking about drinking/smoking/using" — invites the same understanding.

This matters because stigma remains one of the most significant barriers to addiction treatment. People with substance use disorders often internalize shame about their inability to "just stop," interpreting craving as evidence of weak character rather than dysregulated neurobiology. The drug noise framework offers an alternative: your brain is generating noise, and that noise can potentially be turned down pharmacologically.

The Neuroscience Behind the Metaphor

The food noise/drug noise framework maps directly onto the incentive salience model developed by neuroscientists Kent Berridge and Terry Robinson. Their research distinguishes between "liking" (the hedonic pleasure of consuming a reward) and "wanting" (the motivational drive to pursue it). In both obesity and addiction, "wanting" becomes pathologically amplified while "liking" may remain normal or even decrease.

GLP-1 agonists appear to primarily reduce "wanting" — the assignment of motivational importance to rewarding stimuli. They turn down the volume on the signal that says "you need this" without eliminating the capacity to enjoy normal pleasures. This is why patients don't describe GLP-1 medications as making food or alcohol unpleasant. They describe them as making food or alcohol unimportant.

A Shared Biology, Not a Metaphor

The food noise/drug noise parallel is not just a useful analogy. It reflects genuine biological overlap. GLP-1 receptors in the ventral tegmental area and nucleus accumbens modulate the same dopamine circuitry that drives both food-seeking and drug-seeking behavior. The WashU BMJ study's finding that GLP-1 medications reduce the risk of developing substance use disorders across all five major substance categories simultaneously provides population-level evidence that the "noise" is generated by a single shared mechanism.

Moving from food noise to drug noise isn't just a rebranding exercise. It's a reconceptualization of addiction as a disorder of reward salience — and a recognition that the same pharmacological approach that addresses one manifestation of that disorder may address them all.